Presumed ocular histoplasmosis syndrome in a commercially insured population, United States.
PURPOSE:To describe epidemiologic features of patients with presumed ocular histoplasmosis syndrome (POHS) in the United States using insurance claims data and compare POHS patients with and without choroidal neovascularization (CNV). DESIGN:Retrospective cohort study. METHODS:Patients with Internat...
Main Authors: | Kaitlin Benedict, Jessica G Shantha, Steven Yeh, Karlyn D Beer, Brendan R Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230305 |
Similar Items
-
Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
by: Kaitlin Benedict, et al.
Published: (2020-11-01) -
Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
by: Turgut Yılmaz, et al.
Published: (2017-03-01) -
Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
by: Kaitlin Benedict, et al.
Published: (2020-06-01) -
Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
by: Kaitlin Benedict, et al.
Published: (2020-03-01) -
Evolution of Choroidal Neovascularization due to Presumed Ocular Histoplasmosis Syndrome on Multimodal Imaging including Optical Coherence Tomography Angiography
by: T. Y. Alvin Liu, et al.
Published: (2018-01-01)